The Ireland chapter covers the Irish legal and regulatory framework governing pharmaceutical advertising, including promotion to healthcare professionals and the public, gifts and financial incentives, hospitality, transparency obligations, and digital and social media advertising. It also examines recent developments, including updates to the IPHA Code of Practice, increased regulatory scrutiny of online advertising, and anticipated changes arising from EU pharmaceutical reform.

Colin Kavanagh (Partner), Orla Clayton (Of Counsel), Bridget Clinton (Senior Associate) and Robert Byrne (Associate) from our Life Sciences Group have authored the Ireland chapter of the guide. Associates Aoibhín Ní Dhubháin and Aoife O’Malley, also members of our Life Sciences Group, contributed to the preparation of this chapter.

Read the Ireland chapter of Pharmaceutical Advertising 2026 via the ICLG website.

This article was first published in ICLG – Pharmaceutical Advertising 2026.